US Broker Ratings

Immatics N.V. (IMTX) Stock Analysis: Riding the Biotechnology Wave with an 80.81% Potential Upside

German biopharmaceutical company Immatics N.V. (NASDAQ: IMTX) is making waves in the biotechnology sector with its cutting-edge approach to cancer treatment. At the heart of the company’s innovation are its..

Community Health Systems, Inc. (CYH) Stock Analysis: Unpacking a 21.72% Potential Upside Amidst Healthcare Volatility

Community Health Systems, Inc. (NYSE: CYH) presents a complex yet intriguing opportunity for investors looking to tap into the healthcare sector. With its operations deeply embedded in the medical care..

Claritev Corporation (CTEV) Stock Analysis: A 99% Upside Beckons as Analysts Rally Behind Healthcare Innovator

Claritev Corporation (CTEV) is capturing the attention of investors with its robust potential for growth, particularly in the burgeoning sector of healthcare information services. Headquartered in New York, Claritev offers..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 71% Upside Potential in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is drawing significant attention in the biotechnology sector, not just for its ambitious therapeutic developments but also for its remarkable potential upside of 71.16% as..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Biotech with 89% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a cutting-edge player in the biotechnology sector, is capturing investor attention with its promising potential upside of 89.21%. With a focus on engineered cell therapies..

Embecta Corp. (EMBC) Stock Analysis: Navigating Market Challenges with a 37.97% Upside Potential

Embecta Corp. (NASDAQ: EMBC), a stalwart in the medical instruments and supplies industry, is currently trading at $12.08, reflecting a modest price change of 0.16 (0.01%). Despite a challenging 52-week..

Arvinas, Inc. (ARVN) Stock Analysis: A Biotech Innovator with Phase 3 Trials on the Horizon

Arvinas, Inc. (NASDAQ: ARVN) is a clinical-stage biotechnology company situated in the healthcare sector, specializing in the innovative field of targeted protein degradation. With a market capitalization of $893.49 million,..

AbCellera Biologics Inc. (ABCL): Analyzing a Promising 164% Upside in the Biotech Sector

AbCellera Biologics Inc. (ABCL) stands out in the biotech industry with its innovative approach to antibody-based medicine discovery. Headquartered in Vancouver, Canada, AbCellera operates in the healthcare sector, specifically within..

Maravai LifeSciences Holdings (MRVI): Navigating a 19% Potential Upside Amidst Challenging Metrics

For investors seeking opportunities within the biotechnology sector, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a mix of potential and challenges. Based in San Diego, California, Maravai is a key..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unveiling a 3,575.80% Revenue Surge and Promising Biotechnology Innovations

Investors with a keen eye on the biotechnology sector should take a closer look at Keros Therapeutics, Inc. (NASDAQ: KROS), a dynamic player in the healthcare industry known for its..

Immunome, Inc. (IMNM) Stock Analysis: A Promising Biotech Play with 53% Upside Potential

Immunome, Inc. (NASDAQ: IMNM), a biotechnology company specializing in targeted cancer therapies, has been capturing the attention of investors with its robust pipeline and significant upside potential. Based in Bothell,..

iRadimed Corporation (IRMD) Stock Analysis: Riding High with Strong Revenue Growth and Analyst Confidence

iRadimed Corporation (IRMD), a dynamic player in the healthcare sector specializing in medical devices, has been capturing investor attention with its impressive market performance and solid growth metrics. Headquartered in..

InMode Ltd. (INMD) Stock Analysis: Unveiling Growth Potential Amidst Market Challenges

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has captured attention with its innovative approach to aesthetic medical products. The Israeli..

CeriBell, Inc. (CBLL) Stock Analysis: A Medical Device Innovator with 31% Revenue Growth and Strong Buy Ratings

CeriBell, Inc. (CBLL) has been making waves in the medical devices industry, focusing on transforming the diagnosis and management of neurological conditions. As a healthcare company headquartered in Sunnyvale, California,..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A Biotech Star with 23.79% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Cogent Biosciences, Inc. (NASDAQ: COGT) presents a compelling case. The company, headquartered in Waltham, Massachusetts, is at the forefront of developing precision..

Evolus, Inc. (EOLS) Stock Analysis: Unveiling a 170% Upside Potential for Savvy Investors

Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, specializes in the cash-pay aesthetic market with its innovative product offerings. Headquartered in Newport Beach, California, Evolus is making..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: Navigating a 117% Revenue Growth in Biotech

Stoke Therapeutics, Inc. (NASDAQ: STOK), a burgeoning player in the biotechnology sector, is capturing investor attention with its impressive 117.20% revenue growth. With a current market cap of $1.84 billion,..

Butterfly Network, Inc. (BFLY) Investor Outlook: Analyzing Growth Potential in the Medical Devices Sector

Butterfly Network, Inc. (NASDAQ: BFLY) is capturing investor attention with its innovative approach to ultrasound imaging. Nestled in the thriving healthcare sector and focusing on the medical devices industry, this..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unpacking a Potential 150% Upside in the Biotech Arena

Gyre Therapeutics, Inc. (NASDAQ: GYRE) has recently caught the eye of investors with its promising potential for growth, marked by a compelling 150.35% potential upside. Operating within the biotechnology industry,..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unveiling a Potential 181% Upside in the Biotechnology Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) is capturing the attention of investors with its intriguing growth potential in the biotechnology sector. Based in San Francisco, this clinical-stage biopharmaceutical company is focused..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds